Works matching IS 20754426 AND DT 2018 AND VI 8 AND IP 2
Results: 8
ENABLE 2017, the First EUROPEAN PhD and Post-Doc Symposium. Session 3: In Vitro to In Vivo: Modeling Life in 3D.
- Published in:
- Journal of Personalized Medicine, 2018, v. 8, n. 2, p. 20, doi. 10.3390/jpm8020020
- By:
- Publication type:
- Article
Insurance Coverage Policies for Pharmacogenomic and Multi-Gene Testing for Cancer.
- Published in:
- Journal of Personalized Medicine, 2018, v. 8, n. 2, p. 19, doi. 10.3390/jpm8020019
- By:
- Publication type:
- Article
Correction: Antoniou, M.; et al. Fixed and Adaptive Parallel Subgroup-Specific Design for Survival Outcomes: Power and Sample Size. J. Pers. Med. 2017, 7, 19.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Correction: Antoniou, M.; et al. Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review. J. Pers. Med. 2017, 7, 1.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Applicability of Precision Medicine Approaches to Managing Hypertension in Rural Populations.
- Published in:
- Journal of Personalized Medicine, 2018, v. 8, n. 2, p. 16, doi. 10.3390/jpm8020016
- By:
- Publication type:
- Article
Ten Years’ Experience with the CYP2D6 Activity Score: A Perspective on Future Investigations to Improve Clinical Predictions for Precision Therapeutics.
- Published in:
- Journal of Personalized Medicine, 2018, v. 8, n. 2, p. 15, doi. 10.3390/jpm8020015
- By:
- Publication type:
- Article
Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition.
- Published in:
- Journal of Personalized Medicine, 2018, v. 8, n. 2, p. 14, doi. 10.3390/jpm8020014
- By:
- Publication type:
- Article
Genomic Profiling on an Unselected Solid Tumor Population Reveals a Highly Mutated Wnt/β-Catenin Pathway Associated with Oncogenic EGFR Mutations.
- Published in:
- Journal of Personalized Medicine, 2018, v. 8, n. 2, p. 13, doi. 10.3390/jpm8020013
- By:
- Publication type:
- Article